Published in Korean J Pathol on June 22, 2012
Update on the proposal for creating a guideline for cancer registration of the gastrointestinal tumors (I-2). Korean J Pathol (2012) 1.05
A proposal for creating a guideline for cancer registration of the fibromatosis, PEComa group, malignant lymphoma In Situ and dendritic cell tumors (III). Korean J Pathol (2012) 0.78
Review of Medical Advisory Services by the Korean Society of Pathologists from 2003 to 2014. J Pathol Transl Med (2015) 0.75
Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat (2005) 11.27
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol (2004) 6.20
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat (2011) 4.21
Mucinous tumors of the ovary: a review. Int J Gynecol Pathol (2005) 1.81
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol (1999) 1.45
Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors. Am J Surg Pathol (1999) 1.30
Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer (1988) 1.22
Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer (2002) 1.22
Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol (2001) 1.08
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol (2006) 1.07
Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up. Am J Surg Pathol (1998) 0.96
Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast (2006) 0.96
Mammary ductal carcinoma in situ with microinvasion. Cancer (1998) 0.91
Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstet (1991) 0.88
Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment. Arch Surg (1989) 0.88
Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol (1977) 0.87
Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Pathol Int (2003) 0.87
Ductal carcinoma in situ with microinvasion: clinicopathologic study and biopathologic profile. Pathol Res Pract (2006) 0.85
Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Cancer (2000) 0.85
Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol (1990) 0.84
Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys (1992) 0.83
Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion? Am J Surg Pathol (2007) 0.79
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol (2006) 2.92
Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet (2008) 2.14
Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf) (2004) 1.96
Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy. Clin Endocrinol (Oxf) (2005) 1.95
Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat (2007) 1.92
Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) (2004) 1.87
Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat (2013) 1.79
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2006) 1.77
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab (2011) 1.74
The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol (2011) 1.71
Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res (2005) 1.70
In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials (2006) 1.61
Infantile hemangioendothelioma with elevated serum alpha fetoprotein: report of 2 cases with immunohistochemical analysis. Hum Pathol (2010) 1.56
Thermal kinetics of color degradation of mulberry fruit extract. Nahrung (2003) 1.55
Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother (2005) 1.55
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis? Chest (2007) 1.53
Radiologic and clinical features of idiopathic granulomatous lobular mastitis mimicking advanced breast cancer. Yonsei Med J (2006) 1.50
Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A (2005) 1.48
MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model. Radiology (2003) 1.47
The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) (2005) 1.35
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes (2009) 1.31
Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood (2002) 1.30
Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid (2007) 1.30
Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma. Hum Pathol (2006) 1.30
18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope (2005) 1.28
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2009) 1.27
Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene (2003) 1.27
Polypoid arteriovenous malformation of colon mimicking inflammatory fibroid polyp. J Gastroenterol (2004) 1.23
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (2008) 1.23
Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer (2013) 1.22
CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle. J Biol Chem (2003) 1.22
Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer (2007) 1.18
Expression of aquaporin 5 (AQP5) promotes tumor invasion in human non small cell lung cancer. PLoS One (2008) 1.17
CRIF1 is essential for the synthesis and insertion of oxidative phosphorylation polypeptides in the mammalian mitochondrial membrane. Cell Metab (2012) 1.17
Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer. Clin Cancer Res (2012) 1.17
Adenocarcinoma arising in gastric heterotopic pancreas: a case report. J Korean Med Sci (2004) 1.14
Mouse emi1 has an essential function in mitotic progression during early embryogenesis. Mol Cell Biol (2006) 1.13
18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab (2007) 1.11
Benign metastasizing leiomyoma: metastasis to rib and vertebra. Ann Thorac Surg (2011) 1.10
Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci (2010) 1.08
Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers. Breast Cancer Res Treat (2006) 1.07
Newly identified tumor-associated role of human Sharpin. Mol Cell Biochem (2010) 1.07
Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E. J Clin Endocrinol Metab (2010) 1.07
(4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies. J Nucl Med (2012) 1.07
Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation. Mol Endocrinol (2003) 1.06
Imaging features of metaplastic carcinoma with chondroid differentiation of the breast. AJR Am J Roentgenol (2007) 1.06
Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype. Breast Cancer Res (2013) 1.05
Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer (2009) 1.04
Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer. Pathol Int (2006) 1.04
Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. Mod Pathol (2012) 1.04
Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Diagn Microbiol Infect Dis (2005) 1.03
Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing. Thyroid (2013) 1.03
Small cell extraskeletal osteosarcoma. Orthopedics (2009) 1.02
PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65. Nat Commun (2013) 1.02
Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice. Oncogene (2004) 1.02
Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups. J Surg Oncol (2011) 1.02
Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant (2010) 1.01
HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis. Gastroenterology (2006) 1.01
The HCCR oncoprotein as a biomarker for human breast cancer. Clin Cancer Res (2005) 1.00
VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy. EMBO Mol Med (2013) 1.00
Thymic metastasis in breast cancer: a case report. Korean J Radiol (2007) 1.00
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. Thyroid (2012) 1.00
Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res (2007) 0.99
The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium. Clin Exp Metastasis (2003) 0.99
Tumors of the central nervous system in Korea: a multicenter study of 3221 cases. J Neurooncol (2002) 0.99
Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status. Breast (2011) 0.99
Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma. J Gastroenterol Hepatol (2003) 0.98
Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol (2008) 0.97
Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells. Carcinogenesis (2006) 0.96
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in patients with breast cancer following neoadjuvant chemotherapy. J Breast Cancer (2012) 0.96
Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Hum Pathol (2005) 0.96
Renal cell carcinoma metastatic to follicular adenoma of the thyroid gland. A case report. Acta Cytol (2004) 0.95
Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice. PLoS Genet (2013) 0.95
Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas. Mod Pathol (2003) 0.95
Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck (2007) 0.94
Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis. Int J Med Sci (2012) 0.94
Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: distinct subtype with an indolent clinical course. Pathol Int (2009) 0.94
Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. Yonsei Med J (2006) 0.94
Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system. Am J Clin Pathol (2010) 0.94
Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component. Arch Pathol Lab Med (2005) 0.94
Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental. Clin Endocrinol (Oxf) (2010) 0.94
Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma. PLoS One (2011) 0.93
Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma. J Clin Endocrinol Metab (2012) 0.93
Bilateral xanthogranuloma of the breast: radiologic findings and pathologic correlation. J Ultrasound Med (2007) 0.93
High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. Cancer Lett (2012) 0.93
Fine needle aspiration cytology of CD56-positive natural killer/T-cell lymphoma of soft tissue. Cancer (2002) 0.93
Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med (2005) 0.93
Self-assembled foam-like graphene networks formed through nucleate boiling. Sci Rep (2013) 0.93
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J Pathol (2014) 0.93
Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm". Korean J Intern Med (2003) 0.92
Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. APMIS (2013) 0.92
Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC. BMC Cancer (2008) 0.92
Hepatitis B reactivation during adjuvant anthracycline-based chemotherapy in patients with breast cancer: a single institution's experience. Korean J Intern Med (2007) 0.91
Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. Am J Obstet Gynecol (2003) 0.91
Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer. Mod Pathol (2011) 0.91
High frequency of genetic alterations in non-small cell lung cancer detected by multi-target fluorescence in situ hybridization. J Korean Med Sci (2007) 0.91